Poseida Therapeutics, Inc. (Nasdaq:PSTX)

Health Care/Life Sciences • Pharmaceuticals

CIK 1661460

Company

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Address
9390 Towne Centre Drive
Suite 200
San Diego, California 92121

Employees
314

Stock Info

Close
$3.4800

Day Range
3.4000 - 3.7500

52 Week Range
1.5400 - 5.4800

Average volume
949.63K

Short Interest
3.67M (02/15/24)

% of Float Shorted
5.94%

Market Cap
$352.38M

Revenue
$130.49M

Net Income
-$64M

2020 Sales Growth
N/A

Rev. per Employee
$158.47K

P/E Ratio
N/A

EPS
-$1.5001

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Executive Chairman
Mark J Gergen

President, Chief Executive Officer & Director
Kristin Yarema PhD

Director
Rafael G Amado MD

Director
Cynthia L Collins MBA

Independent Director
Marcea Bland Lloyd

Independent Director
Charles M Baum MD, PhD

Independent Director
Luke Corning

Independent Director
John P Schmid MBA

SEC filings

Date	Form	Event
11 Dec, 2024	4
9 Dec, 2024	SC TO-T
9 Dec, 2024	SC 14D9
27 Nov, 2024	4
27 Nov, 2024	SC14D9C
27 Nov, 2024	SC 13D/A
26 Nov, 2024	SC TO-C
26 Nov, 2024	8-K
26 Nov, 2024	SC14D9C
26 Nov, 2024	SC TO-C
26 Nov, 2024	144
14 Nov, 2024	8-K
8 Nov, 2024	SC 13G
7 Nov, 2024	8-K
7 Nov, 2024	10-Q
22 Oct, 2024	SC 13G
30 Sep, 2024	8-K
14 Aug, 2024	EFFECT
12 Aug, 2024	CORRESP
8 Aug, 2024	UPLOAD
5 Aug, 2024	10-Q
5 Aug, 2024	8-K
5 Aug, 2024	S-3
18 Jun, 2024	4
18 Jun, 2024	8-K
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
18 Jun, 2024	4
7 Jun, 2024	SC 13G/A
14 May, 2024	8-K
14 May, 2024	10-Q
8 May, 2024	SC 13G/A
3 May, 2024	EFFECT
1 May, 2024	CORRESP
1 May, 2024	8-K
25 Apr, 2024	DEF 14A
25 Apr, 2024	DEFA14A
25 Apr, 2024	ARS
17 Apr, 2024	8-K
11 Apr, 2024	UPLOAD
8 Apr, 2024	S-3
8 Apr, 2024	8-K
3 Apr, 2024	3
3 Apr, 2024	4
7 Mar, 2024	8-K
7 Mar, 2024	10-K
4 Mar, 2024	4
4 Mar, 2024	4
4 Mar, 2024	4
4 Mar, 2024	4
9 Feb, 2024	SC 13G/A
8 Feb, 2024	S-8
2 Feb, 2024	4
31 Jan, 2024	SC 13G
4 Jan, 2024	4
4 Jan, 2024	4
4 Jan, 2024	8-K
11 Dec, 2023	8-K
9 Nov, 2023	10-Q
9 Nov, 2023	8-K
10 Oct, 2023	8-K	CEO Change
14 Aug, 2023	SC 13D
11 Aug, 2023	D
8 Aug, 2023	10-Q
8 Aug, 2023	8-K
7 Aug, 2023	8-K
17 Jul, 2023	UPLOAD
7 Jul, 2023	CORRESP
22 Jun, 2023	UPLOAD
16 Jun, 2023	4
16 Jun, 2023	8-K
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
16 Jun, 2023	4
1 Jun, 2023	8-K
9 May, 2023	8-K
9 May, 2023	10-Q
2 May, 2023	4
26 Apr, 2023	DEF 14A
26 Apr, 2023	DEFA14A
26 Apr, 2023	ARS
14 Apr, 2023	3
13 Apr, 2023	8-K
12 Apr, 2023	4
12 Apr, 2023	3
30 Mar, 2023	8-K
9 Mar, 2023	10-K
9 Mar, 2023	8-K
2 Mar, 2023	4
2 Mar, 2023	4
2 Mar, 2023	4
2 Mar, 2023	4
22 Feb, 2023	8-K
9 Feb, 2023	SC 13G/A
3 Feb, 2023	4
3 Feb, 2023	4
31 Jan, 2023	8-K
17 Jan, 2023	5
12 Jan, 2023	S-8
6 Dec, 2022	8-K
1 Dec, 2022	8-K
10 Nov, 2022	8-K
10 Nov, 2022	10-Q
7 Sep, 2022	8-K
11 Aug, 2022	8-K
11 Aug, 2022	10-Q
10 Aug, 2022	4
10 Aug, 2022	4
5 Aug, 2022	4
4 Aug, 2022	8-K
4 Aug, 2022	424B5
3 Aug, 2022	8-K
3 Aug, 2022	8-K
3 Aug, 2022	424B5
17 Jun, 2022	4
16 Jun, 2022	8-K
16 Jun, 2022	4
16 Jun, 2022	4
16 Jun, 2022	4
16 Jun, 2022	4
25 May, 2022	DEFA14A
18 May, 2022	3
18 May, 2022	8-K
12 May, 2022	8-K
12 May, 2022	10-Q
27 Apr, 2022	DEF 14A
27 Apr, 2022	DEFA14A
25 Apr, 2022	SC 13D/A
7 Apr, 2022	8-K
18 Mar, 2022	4
10 Mar, 2022	8-K
10 Mar, 2022	10-K
1 Mar, 2022	4
1 Mar, 2022	3
1 Mar, 2022	4
1 Mar, 2022	4
1 Mar, 2022	4
1 Mar, 2022	4
23 Feb, 2022	8-K
22 Feb, 2022	8-K
18 Feb, 2022	S-8
17 Feb, 2022	8-K
9 Feb, 2022	SC 13G/A
1 Feb, 2022	8-K	CEO Change
1 Feb, 2022	4
1 Feb, 2022	4
10 Jan, 2022	8-K	CEO Change
22 Dec, 2021	4
8 Dec, 2021	4
7 Dec, 2021	4
2 Dec, 2021	4
29 Nov, 2021	4
23 Nov, 2021	4
22 Nov, 2021	4
18 Nov, 2021	4
18 Nov, 2021	4
10 Nov, 2021	4
9 Nov, 2021	8-K
9 Nov, 2021	10-Q
2 Nov, 2021	4
13 Oct, 2021	4
13 Oct, 2021	8-K
12 Oct, 2021	8-K
5 Oct, 2021	4
22 Sep, 2021	4
15 Sep, 2021	4
10 Sep, 2021	4
3 Sep, 2021	4
31 Aug, 2021	8-K
27 Aug, 2021	4
24 Aug, 2021	4
20 Aug, 2021	EFFECT
18 Aug, 2021	UPLOAD
18 Aug, 2021	CORRESP
13 Aug, 2021	S-3
12 Aug, 2021	10-Q
12 Aug, 2021	8-K
10 Aug, 2021	4
4 Aug, 2021	4
30 Jul, 2021	4
26 Jul, 2021	4
26 Jul, 2021	4
26 Jul, 2021	4
26 Jul, 2021	4
26 Jul, 2021	3
26 Jul, 2021	8-K
6 Jul, 2021	4
21 Jun, 2021	4
17 Jun, 2021	8-K
17 Jun, 2021	4
17 Jun, 2021	4
17 Jun, 2021	4
14 Jun, 2021	4
8 Jun, 2021	S-8
3 Jun, 2021	4
11 May, 2021	8-K
11 May, 2021	10-Q
5 May, 2021	3/A
5 May, 2021	4
28 Apr, 2021	DEFA14A
28 Apr, 2021	DEF 14A
23 Apr, 2021	4
5 Apr, 2021	4
11 Mar, 2021	8-K
11 Mar, 2021	10-K
3 Mar, 2021	4
25 Feb, 2021	4
24 Feb, 2021	8-K
23 Feb, 2021	8-K
17 Feb, 2021	4
12 Feb, 2021	4
12 Feb, 2021	SC 13G
8 Feb, 2021	SC 13G/A
5 Feb, 2021	4
5 Feb, 2021	4
5 Feb, 2021	4
5 Feb, 2021	4
5 Feb, 2021	4
5 Feb, 2021	4
3 Feb, 2021	SC 13G
25 Jan, 2021	4
19 Jan, 2021	4
19 Jan, 2021	4
11 Jan, 2021	4

Last update:2024-03-06 13:07:40.832736

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.